PMVP (PMVP) Stock Price & Analysis
PMVP (PMVP) rose 4.03% to USD 1.29 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.
PMVP last closed at USD 1.29; the session ranged USD 1.24–1.35 on volume of 529,983 shares. Market capitalization is —, with a 52-week range of USD 1.02–1.88 (NMS). Source: Nexqual, September 8, 2026 at 05:01 UTC.
Key Statistics (as of September 8, 2026 at 05:01 UTC)
| Price | USD 1.29 |
|---|---|
| Change | ▲ 4.03% (up) |
| Previous Close | USD 1.29 |
| Open | USD 1.29 |
| Day Range | USD 1.24 – 1.35 |
| 52-Week Range | USD 1.02 – 1.88 |
| Volume | 529,983 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PMVP)
Nexqual's technical model rates PMVP "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 51.56 (neutral) |
| vs SMA50 | Above (USD 1.25) |
| MACD | 0.01 (positive) |
From PMVP's Latest SEC 10-K Filing (filed 2026-03-06)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRLD | Prelude Therapeutics Incorporat | USD 5.46 | ▲ 0.55% |
| ALXO | ALX Oncology Holdings Inc. | USD 2.01 | ▼ 3.37% |
| NKTX | Nkarta, Inc. | USD 2.92 | ▲ 5.61% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | USD 3.99 | ▲ 5.84% |
| CCCC | C4 Therapeutics, Inc. | USD 3.76 | ▼ 0.79% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.